Table 8.
Year | State | Treatment | Aflatoxin concentration (ppb)x | Dominant MLHz | |
---|---|---|---|---|---|
Afla-Guardy | AF36y | ||||
2012 | Alabama | Treated | 5.96a | – | H96 |
Untreated | 27.85a | – | |||
Georgia | Treated | – | – | H96 | |
Untreated | – | – | |||
North Carolina | Treated | 2.75a | 4.75a | H96 | |
Untreated | 103.75b | 103.75b | |||
2013 | Alabama | Treated | 2.20a | 1.28a | H96 |
Untreated | 2.04a | 2.04a | |||
Georgia | Treated | 5.00a | – | H96 | |
Untreated | 9.00a | – | |||
North Carolina | Treated | 1.25a | 5.08a | H96 | |
Untreated | 11.43a | 11.43a |
Aflatoxin concentrations followed by the same letter are not significantly different at α = 0.05.
Afla-Guard was not evaluated in Georgia in 2012, while AF36 was not evaluated in Alabama in 2012 and in Georgia in 2012 and 2013.
H96 is the Afla-Guard MLH and belongs to lineage IB.